How much revenue does MPX International make?

MPX International reported 7.21 million CAD in revenue for fiscal year 2021, up 127.4% from 3.17 million CAD in fiscal year 2020. In Q2 2022 revenue was 2.02 million CAD.

What companies are similar to MPX International?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Aeolus Pharmaceuticals, Inc. (AOLS), Immage Biotherapeutics Corp. (IMMG), Halo Collective Inc. (HCANF), Abattis Bioceuticals Corp. (ATTBF).

MPX International Corporation (MPXOF) Stock

About MPX International Corporation

MPX International Corporation, operates as a cannabis company in Canada and internationally. It offers cannabis products under HOLYWEED, beleaf, SALSUS, MPX labs, Canveda, SPARTAN WELLNESS, HIGH12, STRAIN REE, PENNIES, Kingsway, DAIZE, and alice brands. The company was founded in 2015 and is headquartered in Toronto, Canada.

At a glance

MPX International reported revenue of 7.21 million CAD for fiscal year 2021, up 127.4% from fiscal year 2020, and net income of -26.63 million CAD. In Q2 2022 (the quarter ended March 31, 2022) revenue was 2.02 million CAD, down 7.6% from a year before.

Figures from company filings; latest fiscal year ended September 30, 2021.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.